Daily online news source and weekly report on market data and business trends provide in-depth coverage of the biopharmaceutical industry, with topics covered by these news sources including new product development, clinical trials, FDA approvals, regulatory updates, market performance, corporate financings, strategic alliances, mergers and acquisitions, and corporate restructurings.
Biennial report examines the economic value of bioscience innovation on an national and state basis, with topics covered on a state-by-state basis including establishment, employment, and wage trends, research and development expenditures, NIH funding levels, venture capital investments, and patent awards by bioscience-related class group. Full study and individual state profiles are available online.
Comprehensive report provides in-depth analysis of the biotechnology sector, with topics covered in the report including major trends and developments, public offerings and other financing and capital sources, mergers and acquisitions, underwriter and stock performance, restructuring transactions, and pending litigation. Detailed table of contents and excerpts from the report can be viewed online.
Standard & Poor's survey provides in-depth coverage of the biotech industry, with topics covered in the report including industry performance and trends, operational overview, and key industry ratios and statistics, and with companies covered in the comparative company analysis section including Abbvie Inc., Amgen, Inc., Biogen, Inc., Gilead Sciences, Inc., and Regeneron Pharmaceuticals, Inc.
Comprehensive market research report provides in-depth analysis of the biopharmaceutical market in the U.S. and other countries, with data provided including historical and forecast sales by product segment (e.g., recombinant proteins, monoclonal antibodies, insulin, and vaccines) and companies profiled including AbbVie Inc., Eli Lilly and Company, Genentech, Inc., Pfizer, Inc., and Novartis AG.
Market analysis report provides industry statistics for a user-defined area on a national, state, county, metro area, or zip code level, with data provided including number of companies, market volume and sales trends, average company sales, sales per employee, staffing and employment trends, average employee wage, and business start up activity and failure rates. Sample report can be viewed online.
Financial benchmarking section of these reports provides an analysis of industry profit and expenses as a percentage of revenue by major category (e.g., purchases, wages, depreciation, marketing, rent, utilities, other costs, and earnings before interest and taxes) for the most recent year and line graphs indicating trends for each category over the past five years. Sample report can be viewed free online.
Annual executive compensation study provides an in-depth look at salaries, bonuses, other short-term and long-term incentives, and total direct compensation for top-level executives (e.g., chief executive officer, chief financial officer, chief operating officer, research and development officer, business and corporate development officer, and legal officer) of publicly-traded U.S. biopharmaceutical companies.
Annual salary survey provides compensation data for personnel employed by companies engaged in medical, agricultural, and industrial biotechnology activities, with compensation information provided for 12 executive and 153 non-executive salaried job positions including annual base salary, incentive and variable pay such as bonuses, commissions, and rewards, and total direct annual compensation.
Excel spreadsheet provides deal-level data for publicly-announced mergers and acquisitions in this sector over a two-year period, with information provided for these transactions including price paid, deal terms, acquisition target financial performance, and price/revenue and price/income multiples. Single-page excerpt from the spreadsheet that includes sample transaction data is available online.